Cardiovascular News issue 29 – May 2013

388

Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcatheter aortic valve still works after three years in high-risk patients; novel drug could reduce heart damage during angioplasty. Profile: Morton Kern

 

(Visited 26 times, 1 visits today)